3B Pharmaceuticals
  • Targeted Radiotherapy
    • Pipeline
      • Pipeline Chart
      • 3BP Assets
      • Clinical Trials
      • Indications
    • About Nuclear Medicine
      • Imaging
      • Therapy
      • Theragnostics
    • Technology
      • Radiopharmaceuticals
      • Isotopes
    • Publications
    • Partnering
  • About us
    • Team
    • Contact
    • Directions
  • News
  • Careers
  • Search
  • Menu Menu

Archive for month: October, 2024

You are here: Home1 / 2 / 20243 / October
21. October 2024/by imken

3B Pharmaceuticals Announces Option and Asset Purchase Agreement with Novartis for PSMA Radioligand Therapy Program

Read more

https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png 0 0 imken https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png imken2024-10-21 10:19:472024-10-21 10:22:593B Pharmaceuticals Announces Option and Asset Purchase Agreement with Novartis for PSMA Radioligand Therapy Program
  • © 3B Pharmaceuticals
  • Imprint
  • Data privacy statement

3B Pharmaceuticals GmbH
Magnusstraße 11
D-12489 Berlin
Tel: +49 (0)30 / 63 92 - 43 17
Fax: +49 (0)30 / 63 92 - 43 16
info@3b-pharma.com

Scroll to top